Augusta & Co (Augusta), a specialist financial adviser to the renewable energy industry, has overseen the sale of an 80 per cent stake in Finnish utility firm Fortum’s wind portfolio across Norway, Finland and Sweden, accounting for approximately 500MW of operational and construction projects, to funds advised by Credit Suisse
UK mid-market private equity investor Livingbridge is re-investing as a minority shareholder in Sykes Holiday Cottages (Sykes), a UK-basedindependent holiday home provider with over 25 years’ experience in the market.Livingbridge first invested in Sykes in January 2015, when the business managed 5,000 properties in the UK and Ireland. Livingbridge successfully
Intertrust, a provider of tech-enabled fund and corporate solutions to clients operating and investing in the international business environment, has expanded its presence in the aviation finance sector with the acquisition of London-based Wells Fargo Trust Corporation Limited.
Private equity firm MCI Group’s MCI.EuroVentures fund is selling a portion of its shares in Netrisk, an online insurance brokerage in Hungary, to global growth private equity firm TA Associates for EUR55 million (PLN 235 million). As a result of the partial exit, MCI.EuroVentures (buyout fund of MCI Group) has realised
Options, a provider of cloud-enabled managed services to the global capital markets, has secured a significant growth investment from Abry Partners, a Boston-based sector focused private equity firm. The transaction will enable the firm’s executive team to significantly accelerate its growth strategy, pursue strategic M&A targets, invest further in the firm’s technology
Funds managed by Northleaf Capital Partners (Northleaf) have acquired a 90 per cent stake in Douglas Terminals from Hartree Partners (UK) Limited (Hartree) and Ghent Transport & Storage NV (GTS).Douglas Terminals is a 557,000-cubic metre liquid bulk storage terminal based in the Port of Ghent, Belgium. The facility consists of
Varagon Capital Partners, a direct lender to middle market companies, is to form a new strategic partnership with Aflac Global Investments (Aflac) and is extending its existing strategic partnership with American International Group (AIG).Upon closing of the new partnership, Aflac will make a new multi-year investment commitment of up to
Edinburgh-based biotech startup MiAlgae has received an investment of GBP1 million to focus on the commercialisation of its revolutionary microalgae product, targeting the rapidly growing global aquaculture and pet food industries.The biotech business uses co-products from the whisky distillation process to produce microalgae, which is high in omega 3 and
Novo Seeds’ portfolio company, NorthSea Therapeutics a Dutch biotech company developing novel and innovative strategies for the treatment of NASH (Non-alcoholic Steatohepatitis) and other metabolic, inflammatory and fibrotic diseases, has successfully closed a USD40 million (EUR36 million) Series B financing round.The proceeds of this fundraising will be used by NST
British MedTech business, OrganOx Ltd, has secured a GBP4.6 million investment from BGF, the UK and Ireland’s most active investor in growing businesses.The investment will fund commercial expansion of its first product, the metra, in the US, building on commercial traction in Europe, Canada and Australia. OrganOx metra is
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
